The Future Of CGT Manufacturing Panel Discussion: Integrating Digital Solutions With Regulatory Readiness

Cell and gene therapy manufacturers are under pressure to scale breakthrough treatments without compromising quality, traceability, or speed to patients. This discussion brings together experts from across the CGT ecosystem to unpack what it really takes to move from bespoke, batch‑of‑one production to reliable commercial supply. You’ll hear how leading teams are tackling global regulatory complexity, embedding cGMP practices directly into daily operations, and using digital tools to gain real‑time visibility into every step of the process. Explore how AI, advanced analytics, and modular facilities are reshaping what “digitally mature” CGT manufacturing looks like.

If you’re building or scaling CGT operations, gain practical strategies you can apply now to strengthen compliance, reduce deviations, and create more resilient, future‑ready CGT manufacturing.